Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-resistant”

1,677 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,677 results

Large-scale testing (Phase 3)Study completedNCT00054717
What this trial is testing

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

Who this might be right for
HIV Infections
Boehringer Ingelheim 630
Not applicableLooking for participantsNCT03893916
What this trial is testing

MEG Versus EEG HR for the Localization of the Epileptogenic Zone as Part of the Pre-surgical Assessment of Epilepsy

Who this might be right for
Drug-resistant EpilepsyCandidates for Surgical TreatmentEpilepsy
Hospices Civils de Lyon 100
Testing effectiveness (Phase 2)Study completedNCT04437485
What this trial is testing

EIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Who this might be right for
DepressionMajor Depressive DisorderDysthymic Disorder+4 more
Indiana University 46
Early research (Phase 1)Looking for participantsNCT05950464
What this trial is testing

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid Adenocarcinoma+6 more
National Cancer Institute (NCI) 65
Large-scale testing (Phase 3)Study completedNCT06344104
What this trial is testing

Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Who this might be right for
Uncontrolled HypertensionResistant Hypertension
AstraZeneca 326
Not applicableNot Yet RecruitingNCT07382271
What this trial is testing

Evaluation of Safety and Efficacy of Phage Therapy for Drug-resistant Bacterial Infections: An Exploratory, Prospective Single-arm Study

Who this might be right for
Urinary Tract InfectionsUrinary Tract Infections Caused by Drug-resistant Bacteria
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 6
Early research (Phase 1)Study completedNCT01642485
What this trial is testing

Food and Insulin Effect on QT/QTC Interval of ECG

Who this might be right for
Effects of Different Meals on the QT/QTc IntervalInsulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic UseC-Peptide Effects on the QT/QTc Interval+2 more
Richmond Pharmacology Limited 32
Large-scale testing (Phase 3)Study completedNCT00509106
What this trial is testing

Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Forest Laboratories 622
Not applicableLooking for participantsNCT05845255
What this trial is testing

Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data

Who this might be right for
Quality of LifeEpilepsy (treatment Refractory)
MJN Neuroserveis, S.L 130
Not applicableLooking for participantsNCT07145489
What this trial is testing

Infrared Photobiomodulation in Humans With Epilepsy

Who this might be right for
Drug Resistant Epilepsy
Beth Israel Deaconess Medical Center 13
Not applicableActive Not RecruitingNCT04567368
What this trial is testing

TB-CAPT MTB/XDR Study

Who this might be right for
TuberculosisResistance BacterialDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 753
Post-approval studies (Phase 4)Study completedNCT03087890
What this trial is testing

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Who this might be right for
HIV-1-infectionPneumocystis PneumoniaOpportunistic Infections+2 more
University of Bergen 537
Not applicableNot Yet RecruitingNCT07703644
What this trial is testing

Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients

Who this might be right for
Hematologic NeoplasmsGram-Negative Bacterial InfectionsPseudomonas Aeruginosa Infection+2 more
Sizhou Feng 60
Early research (Phase 1)Active Not RecruitingNCT04898634
What this trial is testing

JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 216
Testing effectiveness (Phase 2)Looking for participantsNCT05518578
What this trial is testing

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

Who this might be right for
EpilepsySeizures, Epileptic
Supernus Pharmaceuticals, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00002826
What this trial is testing

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 36
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Not applicableStudy completedNCT02581020
What this trial is testing

The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

Who this might be right for
Hepatitis C Virus
AbbVie 344
Not applicableStudy completedNCT06285110
What this trial is testing

HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen

Who this might be right for
Hiv
University of Bern 1,103
Testing effectiveness (Phase 2)Looking for participantsNCT06422923
What this trial is testing

NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Who this might be right for
Epilepsy, Temporal Lobe
Neurona Therapeutics 10
Next Page